The shares, priced at $17.89, bring the total transaction to $83,277. According to a report from investing.com, the sale was done to meet tax withholding obligations related to the settlement of restricted stock.
Ms. Andrews now has 28,312 shares of Orthofix stock.
In its most recent quarterly report, Orthofix saw $196.6 million in sales.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
